BioQuest Corp
BioQuest Corp. develops and offers AI-powered voice and chat solutions to help organizations automate communication, enhance engagement, and reduce operational costs. It serves a range of industries, including nonprofits and ministries. The company is based in Katy, Texas.
BioQuest Corp (BQST) - Net Assets
Latest net assets as of October 2025: $-929.62K USD
Based on the latest financial reports, BioQuest Corp (BQST) has net assets worth $-929.62K USD as of October 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($59.32K) and total liabilities ($988.95K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-929.62K |
| % of Total Assets | -1567.05% |
| Annual Growth Rate | 31.97% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 4538.0 |
BioQuest Corp - Net Assets Trend (2012–2025)
This chart illustrates how BioQuest Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for BioQuest Corp (2012–2025)
The table below shows the annual net assets of BioQuest Corp from 2012 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-04-30 | $201.72K | +132.17% |
| 2024-04-30 | $-626.98K | -13.24% |
| 2023-04-30 | $-553.65K | -27.87% |
| 2022-04-30 | $-432.99K | +75.53% |
| 2021-04-30 | $-1.77 Million | -1176.92% |
| 2020-04-30 | $-138.58K | -115.83% |
| 2014-04-30 | $875.20K | +9599.69% |
| 2013-04-30 | $9.02K | +64.65% |
| 2012-04-30 | $5.48K | -- |
Equity Component Analysis
This analysis shows how different components contribute to BioQuest Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1170806400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (April 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $29.89K | 14.82% |
| Other Components | $11.88 Million | 5890.45% |
| Total Equity | $201.72K | 100.00% |
BioQuest Corp Competitors by Market Cap
The table below lists competitors of BioQuest Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Medical Marijuana I
PINK:MJNA
|
$1.35 Million |
|
Merchant House International Ltd
AU:MHI
|
$1.35 Million |
|
JS SECURITY TECHN.GRP AB
F:6ZW
|
$1.36 Million |
|
BR01
F:BR01
|
$1.36 Million |
|
FINEQIA INTERN. INC. O.N.
F:FNQA
|
$1.35 Million |
|
SMIS Corporation Bhd
KLSE:7132
|
$1.35 Million |
|
Bürgerliches Brauhaus Ravensburg - Lindau Aktiengesellschaft
STU:BBR
|
$1.35 Million |
|
BECTON DICKINSON&CO - Dusseldorf Stock Exchang
DU:BOX
|
$1.35 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BioQuest Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -626,982 to 201,718, a change of 828,700.
- Net loss of 781,400 reduced equity.
- Other comprehensive income decreased equity by 162,450.
- Other factors increased equity by 1,772,550.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-781.40K | -387.37% |
| Other Comprehensive Income | $-162.45K | -80.53% |
| Other Changes | $1.77 Million | +878.73% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares BioQuest Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 60.19x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 17.48x to 60.19x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-04-30 | $0.06 | $1.04 | x |
| 2013-04-30 | $0.17 | $1.04 | x |
| 2014-04-30 | $32.33 | $1.04 | x |
| 2019-04-30 | $-0.09 | $1.04 | x |
| 2020-04-30 | $-0.03 | $1.04 | x |
| 2021-04-30 | $-0.21 | $1.04 | x |
| 2022-04-30 | $-0.04 | $1.04 | x |
| 2023-04-30 | $-0.05 | $1.04 | x |
| 2024-04-30 | $-0.05 | $1.04 | x |
| 2025-04-30 | $0.02 | $1.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BioQuest Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -387.37%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -541.23%
- • Asset Turnover: 0.13x
- • Equity Multiplier: 5.51x
- Recent ROE (-387.37%) is below the historical average (-54.96%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -0.09% | 0.00% | 0.00x | 1.00x | $-276.42 |
| 2013 | -91.73% | 0.00% | 0.00x | 1.01x | $-9.18K |
| 2014 | -70.38% | 0.00% | 0.00x | 1.02x | $-703.52K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.29K |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-347.65K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.18 Million |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-678.11K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-85.30K |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $62.58K |
| 2025 | -387.37% | -541.23% | 0.13x | 5.51x | $-801.57K |
Industry Comparison
This section compares BioQuest Corp's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BioQuest Corp (BQST) | $-929.62K | -0.09% | N/A | $1.35 Million |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |